Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
Université de Montréal
$27,000.00
Role of Cytotoxic CD4 T Lymphocytes in the Development of Hepatitis C Virus Infection
FY 2025-26
Summary
Hepatitis C virus (HCV) is a blood-borne infection that affects around 50 million people worldwide. While most people who become infected develop chronic infection that can lead to liver damage, about one-third of cases clear the virus naturally thanks to a strong immune response. Current antiviral treatments can cure the infection, but they do not prevent people from being infected again, nor do they restore lasting immunity. Developing an effective vaccine therefore remains an important goal.
The immune system relies on specialized white blood cells called T lymphocytes to fight HCV. In particular, CD8 T cells can kill and destroy infected cells, but in chronic infections, they become exhausted and lose their ability to function. Recent research shows that another subset—CD4 T cells—can also gain the ability to directly kill infected cells, acting as “cytotoxic helper” cells (CD4 CTLs). However, their role in controlling HCV infection is still unclear.
This project aims to understand how CD4 CTLs are involved in the elimination of HCV and why they fail in chronic cases. Using patient samples from the HEPCO biobank, we will analyze how these cells develop and function over time, and how they interact with another subset of T cells, regulatory T cells (Tregs), which can suppress immune responses. We will compare samples from people who cleared the virus naturally and those who developed chronic infection.
By uncovering how CD4 CTLs help control HCV infection, this work will identify new targets for vaccines or immunotherapies to boost antiviral immunity and prevent infection and reinfection.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572813
Name
Kettal Maryam F
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Cytotoxic CD4 T Lymphocytes in the Development of Hepatitis C Virus Infection
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Cd4 Cytotoxic T Lymphocytes (Ctls); Flow Cytometry; Hepatitis C Virus (Hcv); Human Immunology; Regulatory T Cells (Tregs); Viral Infection Response
Abstract
Hepatitis C virus (HCV) is a blood-borne infection that affects around 50 million people worldwide. While most people who become infected develop chronic infection that can lead to liver damage, about one-third of cases clear the virus naturally thanks to a strong immune response. Current antiviral treatments can cure the infection, but they do not prevent people from being infected again, nor do they restore lasting immunity. Developing an effective vaccine therefore remains an important goal.
The immune system relies on specialized white blood cells called T lymphocytes to fight HCV. In particular, CD8 T cells can kill and destroy infected cells, but in chronic infections, they become exhausted and lose their ability to function. Recent research shows that another subset—CD4 T cells—can also gain the ability to directly kill infected cells, acting as “cytotoxic helper” cells (CD4 CTLs). However, their role in controlling HCV infection is still unclear.
This project aims to understand how CD4 CTLs are involved in the elimination of HCV and why they fail in chronic cases. Using patient samples from the HEPCO biobank, we will analyze how these cells develop and function over time, and how they interact with another subset of T cells, regulatory T cells (Tregs), which can suppress immune responses. We will compare samples from people who cleared the virus naturally and those who developed chronic infection.
By uncovering how CD4 CTLs help control HCV infection, this work will identify new targets for vaccines or immunotherapies to boost antiviral immunity and prevent infection and reinfection.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kettal, Maryam F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~